Rescue experiments also demonstrated that the altered gemcitabine resistance in pancreatic cancer caused by RPN6 gain and loss could be reversed by circ-MTHFD1L and miR-615-3p. This evidence concerns the gene PSMD11 and familial pancreatic carcinoma.